CVS enlists Kamen’s Deka in developing home-dialysis machine
Click here to view this article at the source publication

Posted on 7/19/2019 by
Posted in

Human trials have begun on a home-dialysis machine designed by entrepreneur Dean Kamen’s Manchester-based Deka Research & Development Corp., a major step in what could revolutionize the way people with end-stage kidney disease are treated, according to a report by Bloomberg.

The device, called CVS HemoCare, is being tested by CVS Health Corp., which sees the it as a potential entry into what is a $35 billion market.

« Back home